- Home
- DM vs TNYA Comparison
DM vs TNYA Comparison
Compare DM & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DM
- TNYA
- Stock Information
- Founded
- DM 2015
- TNYA 2016
- Country
- DM United States
- TNYA United States
- Employees
- DM N/A
- TNYA N/A
- Industry
- DM Industrial Machinery/Components
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- DM Technology
- TNYA Health Care
- Exchange
- DM Nasdaq
- TNYA Nasdaq
- Market Cap
- DM 87.7M
- TNYA 74.7M
- IPO Year
- DM N/A
- TNYA 2021
- Fundamental
- Price
- DM $2.23
- TNYA $1.11
- Analyst Decision
- DM Hold
- TNYA Strong Buy
- Analyst Count
- DM 1
- TNYA 5
- Target Price
- DM $5.50
- TNYA $17.50
- AVG Volume (30 Days)
- DM 262.9K
- TNYA 1.9M
- Earning Date
- DM 03-14-2025
- TNYA 03-17-2025
- Dividend Yield
- DM N/A
- TNYA N/A
- EPS Growth
- DM N/A
- TNYA N/A
- EPS
- DM N/A
- TNYA N/A
- Revenue
- DM $168,283,000.00
- TNYA N/A
- Revenue This Year
- DM N/A
- TNYA N/A
- Revenue Next Year
- DM $6.25
- TNYA N/A
- P/E Ratio
- DM N/A
- TNYA N/A
- Revenue Growth
- DM N/A
- TNYA N/A
- 52 Week Low
- DM $2.02
- TNYA $0.86
- 52 Week High
- DM $11.80
- TNYA $7.01
- Technical
- Relative Strength Index (RSI)
- DM 40.33
- TNYA 44.41
- Support Level
- DM $2.46
- TNYA $1.43
- Resistance Level
- DM $2.73
- TNYA $1.12
- Average True Range (ATR)
- DM 0.24
- TNYA 0.10
- MACD
- DM 0.01
- TNYA 0.05
- Stochastic Oscillator
- DM 8.40
- TNYA 65.70
About DM Desktop Metal Inc.
Desktop Metal Inc manufactures 3D printing to make metal and carbon fiber 3D printing accessible to all engineers, designers, and manufacturers. 3D metal printing helps in the design and development of automotive parts, consumer goods, manufacture of industrial equipment, and design of mechanical systems. The company ships its product to markets in the Americas, Europe Middle East and Africa (EMEA), and Asia Pacific (APAC). It derives maximum revenue from Americas.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.